Zuga Matt, CFO and Chief Business Officer of Acumen Pharmaceuticals ($ABOS), sold shares on the open market seven times over the past year, totaling nearly $50,000. His most recent sale occurred on January 22, 2026. These transactions rank him in 10,406th place among 11,678 insiders for sales volume, well below the average of $8.6 million per seller across about six trades. Zuga Matt made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 1687 | $1.86 | 304,924.0000 | 60,573,425 | 0.55% | 0.00% |
| Jan. 21, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 2473 | $1.81 | 306,611.0000 | 60,573,425 | 0.80% | 0.00% |
| Jan. 16, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Common Stock | 99133 | $0.00 | 309,084.0000 | 60,573,425 | 47.22% | 0.16% |
| Jan. 16, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Employee Stock Option (right to buy) | 148700 | $0.00 | 148,700.0000 | 60,573,425 | 9999.99% | 0.25% |
| Jan. 8, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 6888 | $1.82 | 209,951.0000 | 60,573,425 | 3.18% | 0.01% |
| Jan. 7, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 4105 | $2.00 | 218,539.0000 | 60,573,425 | 1.84% | 0.01% |
| Jan. 5, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 4000 | $1.96 | 227,744.0000 | 60,573,425 | 1.73% | 0.01% |
| Jan. 7, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 1700 | $1.99 | 216,839.0000 | 60,573,425 | 0.78% | 0.00% |
| Jan. 6, 2026 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 5100 | $1.97 | 222,644.0000 | 60,573,425 | 2.24% | 0.01% |
| May 29, 2025 | ELUTIA INC. | $ELUT | Zuga Matt | Not found | A | Stock Option (Right to Buy) | 60339 | $0.00 | 60,339.0000 | 42,913,111 | 9999.99% | 0.14% |
| Jan. 21, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 4364 | $1.60 | 260,646.0000 | 0 | 1.65% | 0.00% |
| Jan. 23, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 28902 | $1.72 | 231,744.0000 | 0 | 11.09% | 0.00% |
| Jan. 3, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 13235 | $1.84 | 198,210.0000 | 0 | 6.26% | 0.00% |
| Jan. 6, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Common Stock | 66800 | $0.00 | 265,010.0000 | 0 | 33.70% | 0.00% |
| Jan. 6, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Employee Stock Option (right to buy) | 100300 | $0.00 | 100,300.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | ELUTIA INC. | $ELUT | Zuga Matt | Not found | A | Stock Option (Right to Buy) | 31835 | $0.00 | 31,835.0000 | 23,912,326 | 9999.99% | 0.13% |
| Jan. 18, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | S | Common Stock | 4242 | $3.71 | 211,445.0000 | 0 | 1.97% | 0.00% |
| Jan. 2, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Employee Stock Option (right to buy) | 159000 | $0.00 | 159,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO & Chief Business Officer | A | Common Stock | 106000 | $0.00 | 215,687.0000 | 0 | 96.64% | 0.00% |
| Jan. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO and Chief Business Officer | A | Common Stock | 33500 | $0.00 | 109,687.0000 | 0 | 43.97% | 0.00% |
| Jan. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO and Chief Business Officer | A | Employee Stock Option (right to buy) | 150800 | $0.00 | 150,800.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2022 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO and Chief Business Officer | M | Common Stock | 50000 | $1.19 | 76,187.0000 | 0 | 190.93% | 0.00% |
| Dec. 29, 2022 | Acumen Pharmaceuticals, Inc. | $ABOS | Zuga Matt | CFO and Chief Business Officer | M | Stock Option (right to buy) | 50000 | $0.00 | 401,369.0000 | 0 | 11.08% | 0.00% |